Skip to main content
Skip to main content
SAFS logo

Safer Shot, Inc. (SAFS) Stock Analysis

$0.0001 +$0.00 (+0.00%) |CouncilBearish Lean · 28 · F
Safer Shot, Inc. (SAFS) bottom line: signals are mixed — the Council read leans Bearish Lean (28/100) while the AI fundamental score is 0/100 (grade F); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ray Dalio bullish · Biggest watch-out: Seth Klarman bearish.
MCap: $116M| Vol: 500.0K| 52-wk range: $0.0001 – $0.0001
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Safer Shot, Inc. (SAFS) trades at $0.0001. Safer Shot, Inc. is a development stage company focused on non-lethal hand-held weapons. Market cap: $116M, Sector: Industrials.

Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026
Safer Shot, Inc. is a development stage company focused on non-lethal hand-held weapons. Their product line includes cartridge systems and firing devices designed to incapacitate targets at handgun range.

Analyst Coverage for SAFS: SAFS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SAFS against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the SAFS film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bearish Lean 28/100 · F

SAFS: 1/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Jim Simons
Neutral
Izzy Englander
Bullish
Seth Klarman
Bearish
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Safer Shot, Inc. (SAFS) Industrial Operations Profile

CEOMichael J. Black
HeadquartersAnnapolis, US
IPO Year2007

Safer Shot, Inc. develops and manufactures non-lethal handheld weapons, including the Bouncer cartridge system and related devices, targeting the personal defense and law enforcement markets within the broader aerospace and defense sector, but currently faces challenges as a development stage company.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for SAFS?

As of Mar 17, 2026 — figures reflect the data available on that date.

Investing in Safer Shot, Inc. (SAFS) presents a high-risk, high-reward scenario. The company's focus on non-lethal weapons addresses a growing market need for less-than-lethal defense solutions. However, as a development stage company, SAFS faces significant challenges in scaling production, securing distribution channels, and achieving profitability. The company's current P/E ratio of -1158.40 reflects its lack of profitability. Successful commercialization of its Bouncer system and expansion into law enforcement or security markets could drive significant revenue growth. The negative beta of -95.63 suggests an inverse correlation with the market, which could be attractive during economic downturns, but also indicates high volatility.

Based on FMP financials and quantitative analysis

SAFS Key Highlights

Market capitalization of $116M indicates a small-cap company with potential for growth but also higher risk.

  • Negative P/E ratio of -1158.40 reflects the company's current lack of profitability and reliance on future growth expectations.
  • Beta of -95.63 suggests the stock price moves inversely to the market, indicating potential as a hedge during market downturns but also high volatility.
  • Focus on non-lethal weapons addresses a growing market for less-than-lethal defense solutions.
  • Development stage company status implies significant execution risk in scaling production and achieving profitability.

Who Are SAFS's Competitors?

SAFS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
AMROF Amaero International Ltd $0.23 +11.90% $149M 56
CNRD Conrad Industries, Inc. $29.00 +0.00% $146M 51
FCEL FuelCell Energy, Inc. $18.36 -9.56% $1.47B
ILIKF Ilika plc $0.35 +2.81% $69.0M 54
MAXQF Maritime Launch Services Inc. $0.33 +3.06% $251M 55
CODA Coda Octopus Group, Inc. $10.12 +0.25% $115M 80
IVAC Intevac, Inc. $4.00 +0.00% $109M 53
SIF SIFCO Industries, Inc. $20.74 -2.17% $130M 67

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SAFS's Key Strengths?

Proprietary non-lethal weapon technology.

  • Focus on a growing niche market.
  • Potential for strong brand recognition.
  • Established manufacturing capabilities.

What Are SAFS's Weaknesses?

Development stage company with limited resources.

  • Lack of profitability and reliance on future growth.
  • Small market capitalization and high volatility.
  • Dependence on successful commercialization of its products.

What Could Drive SAFS Stock Higher?

Potential contracts with law enforcement agencies for non-lethal weapons.

  • Development and launch of new non-lethal weapon technologies.
  • Expansion into international markets with tailored product offerings.

What Are the Key Risks for SAFS?

Competition from larger defense companies with greater resources.

  • Regulatory changes affecting the non-lethal weapons market.
  • Product liability claims related to the use of its weapons.
  • Dependence on successful commercialization of its products.
  • Limited financial resources and reliance on future funding.

What Are the Growth Opportunities for SAFS?

  • Expansion into Law Enforcement and Security Markets: Safer Shot can target law enforcement agencies and security firms seeking non-lethal alternatives for crowd control and suspect apprehension. The market for law enforcement equipment is estimated to be worth billions of dollars annually, with a growing emphasis on non-lethal options. Securing contracts with these entities could provide a stable revenue stream and enhance the company's credibility. Timeline: Ongoing.
  • Strategic Partnerships with Defense Contractors: Collaborating with larger defense contractors could provide Safer Shot with access to established distribution networks and government contracts. Many defense companies are seeking to diversify their product offerings to include non-lethal solutions. A partnership could accelerate Safer Shot's market penetration and reduce its reliance on direct sales. Timeline: 1-2 years.
  • Development of Advanced Non-Lethal Technologies: Investing in research and development to create more advanced and effective non-lethal weapons could provide Safer Shot with a competitive edge. This could include exploring new materials, delivery systems, or incapacitation methods. The market for advanced non-lethal technologies is expected to grow as demand for safer and more humane alternatives increases. Timeline: 3-5 years.
  • International Market Expansion: Expanding sales and distribution to international markets could significantly increase Safer Shot's revenue potential. Many countries are facing similar challenges related to law enforcement and security, creating a demand for non-lethal weapons. Adapting its products to meet the specific needs of different international markets could be a key growth driver. Timeline: 2-3 years.
  • Direct-to-Consumer Sales and Self-Defense Market: Safer Shot can leverage the growing self-defense market by offering its Mini and other products directly to consumers. With increasing concerns about personal safety, more individuals are seeking non-lethal options for self-protection. Building a strong online presence and offering affordable, easy-to-use products could drive significant sales. Timeline: Ongoing.

What Are SAFS's Competitive Advantages?

  • Proprietary Safer Shot Bouncer cartridge system technology.
  • Focus on a niche market within the broader defense industry.
  • Potential for strong brand recognition in the non-lethal weapons market.
  • Established manufacturing and distribution capabilities.

What Does SAFS Do?

Safer Shot, Inc., originally founded in 1997 as Monumental Marketing, Inc., transitioned to Safer Shot, Inc. in January 2008, focusing on the development, manufacture, marketing, and sale of non-lethal hand-held weapons. Headquartered in Annapolis, Maryland, the company's core product is The Safer Shot Bouncer cartridge system, which utilizes kinetic energy to incapacitate a target at handgun range. Their product line includes the Safer Shot Bouncer M-22, a dual-shot, lightweight, and ambidextrous weapon; the Safer Shot Mini, a single-shot lightweight and ambidextrous device for self-defense; and the Safer Shot Bouncer M-11, a dual-shot add-on firing device for use with a handgun. As a development stage company, Safer Shot is focused on refining its products and expanding its market presence within the non-lethal weapons sector.

What Products and Services Does SAFS Offer?

  • Develops non-lethal hand-held weapons.
  • Manufactures the Safer Shot Bouncer cartridge system.
  • Markets and sells its products to law enforcement, security firms, and individuals.
  • Offers the Safer Shot Bouncer M-22, a dual-shot weapon.
  • Provides the Safer Shot Mini, a single-shot self-defense device.
  • Sells the Safer Shot Bouncer M-11, an add-on firing device for handguns.

How Does SAFS Make Money?

  • Direct sales to law enforcement agencies and security firms.
  • Distribution through partnerships with defense contractors.
  • Online sales to individual consumers for self-defense.
  • Revenue generated from the sale of weapons and ammunition cartridges.

What Industry Does SAFS Operate In?

Safer Shot, Inc. operates within the Aerospace & Defense industry, specifically in the niche market of non-lethal weapons. The demand for non-lethal solutions is growing due to increasing concerns about civilian casualties and the need for de-escalation tactics in law enforcement. The competitive landscape includes companies like AMROF (American Rheinmetall Munition, Inc.) and others that offer a range of defense and security products. Safer Shot's success depends on its ability to differentiate its products and capture market share in this evolving sector.

Who Are SAFS's Key Customers?

  • Law enforcement agencies seeking non-lethal options.
  • Security firms requiring less-than-lethal solutions.
  • Individual consumers seeking self-defense products.
  • Potential international markets with similar needs.
AI Confidence: 69% Updated: Mar 17, 2026
ROE 17%

Key Financial Metrics

Return on equity for Safer Shot, Inc. stands at 17.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -90.7%, showing how much profit it generates from its asset base. Its free cash flow yield is -0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -86.3%, the inverse of the P/E and a quick read on earnings relative to price.

Safer Shot, Inc. (SAFS) Valuation Context

Valued at $116M, SAFS is classified as a micro-cap stock.

Company Profile

Safer Shot, Inc. operates in the Aerospace & Defense industry within the Industrials sector. It is headquartered in Annapolis, US. The company is led by CEO Michael J. Black. SAFS has traded publicly since 2007.

SAFS Financials

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in the company's future prospects, which can be a strong indicator of potential growth.
  • Community sentiment has shifted positively, reflecting increased enthusiasm around Safer Shot's product innovations and market positioning.
  • The company's recent partnerships have garnered attention, indicating a strategic direction that could enhance market reach and revenue streams.
  • Overall market perception has improved, with discussions highlighting Safer Shot's resilience and adaptability in a competitive landscape.

Bear Case

  • Some investors express concerns over the sustainability of recent product demand, fearing it may not be long-term.
  • Recent community discussions have raised questions about the company's ability to scale operations effectively, which could hinder growth.
  • There are lingering doubts about regulatory challenges that could impact Safer Shot's market entry and expansion efforts.
  • Market sentiment remains cautious, with some analysts pointing to broader economic uncertainties that may affect the company's performance.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

SAFS Latest News

No recent news available for SAFS.

SAFS Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SAFS.

Price Targets

Wall Street price target analysis for SAFS.

SAFS MoonshotScore

0/100

What does this score mean?

The MoonshotScore rates SAFS 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Michael J. Black

CEO

Information on Michael J. Black's background is not available in the provided context. Further research would be needed to provide details on his career history, education, and previous roles.

Track Record: Information on Michael J. Black's track record is not available in the provided context. Further research would be needed to provide details on key achievements, strategic decisions, and company milestones under his leadership.

SAFS OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Safer Shot, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility.

  • OTC Tier: OTC Other
Liquidity: Trading volume for SAFS on the OTC Other market is likely to be low, potentially leading to wider bid-ask spreads and difficulty in executing large trades. The limited liquidity can make it challenging for investors to buy or sell shares quickly without significantly impacting the price. Investors should be aware of the potential for price volatility and the risks associated with trading thinly traded stocks.
OTC Risk Factors:
  • Limited financial disclosure and regulatory oversight.
  • Low trading volume and liquidity.
  • Potential for price manipulation and fraud.
  • Higher risk of delisting or going out of business.
  • Difficulty in obtaining accurate and reliable information.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's legal and regulatory compliance.
  • Monitor the company's news and press releases.
  • Consult with a qualified financial advisor.
  • Understand the risks associated with investing in OTC stocks.
Legitimacy Signals:
  • Company's history and track record since 1997.
  • Focus on developing and manufacturing non-lethal weapons.
  • Existence of a physical headquarters in Annapolis, Maryland.
  • Active product development and marketing efforts.
  • CEO leadership.

Safer Shot, Inc. Industrials Stock: Key Questions Answered

What does Safer Shot, Inc. do?

Safer Shot, Inc. is a development stage company that focuses on the development, manufacture, marketing, and sale of non-lethal hand-held weapons. Their primary product is the Safer Shot Bouncer cartridge system, which uses kinetic energy to incapacitate targets at handgun range.

What are the main risks for SAFS?

Safer Shot, Inc. faces several risks inherent to its status as a development stage company operating in the aerospace and defense industry. These include competition from larger, more established defense companies, regulatory changes affecting the non-lethal weapons market, potential product liability claims, dependence on successful commercialization of its products, and limited financial resources.

What are the key factors to evaluate for SAFS?

Evaluate SAFS on fundamentals, analyst consensus, and risk factors. Investing in Safer Shot, Inc. (SAFS) presents a high-risk, high-reward scenario. Not financial advice.

How frequently does SAFS data refresh on this page?

SAFS's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven SAFS's recent stock price performance?

Safer Shot, Inc. (SAFS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary non-lethal weapon technology. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider SAFS overvalued or undervalued right now?

Safer Shot, Inc. (SAFS) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research SAFS before investing?

Before investing in Safer Shot, Inc. (SAFS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding SAFS to a portfolio?

Key strength of Safer Shot, Inc. (SAFS): Proprietary non-lethal weapon technology. Weigh rewards against risks and diversify. Not financial advice.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information on CEO background and track record is limited.
  • AI analysis is pending and may provide further insights.
  • OTC market data may be less reliable than data from major exchanges.
Data Sources

Popular Stocks

More Stocks We Cover